| Dr Stephen Andrew Tarek, DC | |
|
2851 E Manoa Rd Ste 1-205, Honolulu, HI 96822-1858 | |
| (808) 988-6133 | |
| (808) 988-5637 |
| Full Name | Dr Stephen Andrew Tarek |
|---|---|
| Gender | Male |
| Speciality | Chiropractor - Rehabilitation |
| Location | 2851 E Manoa Rd Ste 1-205, Honolulu, Hawaii |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356492052 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 111NR0400X | Chiropractor - Rehabilitation | DC129 (Hawaii) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Stephen Andrew Tarek, DC 2851 East Manoa Road 1-205, Honolulu, HI 96822-1858 Ph: (808) 988-6133 | Dr Stephen Andrew Tarek, DC 2851 E Manoa Rd Ste 1-205, Honolulu, HI 96822-1858 Ph: (808) 988-6133 |
News Archive
Maxim Pharmaceuticals has announced the results of an international Phase 3 clinical trial testing the combination of Ceplene (TM) plus interleukin-2 (IL-2) in 320 patients with acute myeloid leukemia (AML) in complete remission.
Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc. - Florida, has been sued by Pfizer Inc. and Wyeth Pharmaceuticals Inc. in connection with the filing of Watson's Abbreviated New Drug Application for sirolimus tablets in the 1 mg and 2 mg strengths.
Heavy alcohol consumption contributes to numerous problems in Russia, not the least of which is a very high death rate.
AbbVie, a global biopharmaceutical company, and Voyager Therapeutics, Inc., a clinical-stage gene therapy company, today announced that they have entered into an exclusive strategic collaboration and option agreement to develop and commercialize vectorized antibodies directed against tau for the treatment of Alzheimer's disease and other neurodegenerative diseases.
YM BioSciences Inc., is presenting posters on its JAK1/2 inhibiting small molecule (CYT387) and on its novel vascular disrupting agent (CYT997) at the Lorne Cancer Conference in Lorne, Victoria, Australia. CYT387 is an oral JAK1/2 inhibitor, originating from the seminal discovery of JAK1 and JAK2 kinases by Dr. Andrew Wilks, the founder of Cytopia Limited, now YM Australia. CYT997 is an orally-available agent with dual mechanisms of vascular disruption and cytotoxicity and has the potential to be broadly active against a range of tumor types.
› Verified 4 days ago
Beverly Bigbee, DC Chiropractor Medicare: Medicare Enrolled Practice Location: 1221 Kapiolani Blvd, Suite 6a3, Honolulu, HI 96814 Phone: 808-591-8426 | |
Dr. Scott Tobi Hirashiki, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1481 S. King St., #321, Honolulu, HI 96814 Phone: 808-946-4459 Fax: 808-946-8377 | |
Dr. Glenn Thomas Poulain, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 3049 Ualena St, Suite 104, Honolulu, HI 96819 Phone: 808-834-8662 | |
Dr. Francis G Brewer, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1150 S King St, Suite 604, Honolulu, HI 96814 Phone: 808-593-0313 Fax: 808-589-2032 | |
Piianaia Ohana Chiropractic Inc Chiropractor Medicare: Medicare Enrolled Practice Location: 3221 Waialae Avenue, Ste 330, Honolulu, HI 96816 Phone: 808-735-8749 Fax: 808-734-2766 | |
Dr. Joseph Patrick Breuwet, D.C. Chiropractor Medicare: May Accept Medicare Assignments Practice Location: 1600 Kapiolani Blvd, Suite 1421, Honolulu, HI 96814 Phone: 808-638-1313 Fax: 808-942-9493 | |
Howard Tang D.c.p.c. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1191 Bethel Street, Honolulu, HI 96813 Phone: 808-524-9913 Fax: 808-524-8815 |